Prof. Dr. Schröck
Advisory Board Member
Radiology
Applied Spectral Imaging
Israel
Biography
Prof. Schröck has many years’ experience in the genetic investigation of brain tumors and other cancers, using spectral karyotyping (SKY) and comparative genomic hybridization (CGH) Among her current research studies, Prof Schröck examined tumors using genome-wide high-throughput sequencing (next generation sequencing). An important goal of her research is accurate and fast scientific findings which then can be implemented into clinical trials and ultimately, used in patient care. Dr. Schröck has also recently been appointed as President of Scientific Board of International Society of Cellular Oncology (ISCO). ISCO is a strong alliance of active researchers in the field of cancer that crosses many disciplines including medical oncology, molecular and cell pathology, genomics, proteomics, epigenomics, biochemistry, specialist microscopy, molecular imaging, biotechnology and bioinformatics.
Research Interest
Prof. Schröck has many years’ experience in the genetic investigation of brain tumors and other cancers, using spectral karyotyping (SKY) and comparative genomic hybridization (CGH) Among her current research studies, Prof Schröck examined tumors using genome-wide high-throughput sequencing (next generation sequencing). An important goal of her research is accurate and fast scientific findings which then can be implemented into clinical trials and ultimately, used in patient care. Dr. Schröck has also recently been appointed as President of Scientific Board of International Society of Cellular Oncology (ISCO). ISCO is a strong alliance of active researchers in the field of cancer that crosses many disciplines including medical oncology, molecular and cell pathology, genomics, proteomics, epigenomics, biochemistry, specialist microscopy, molecular imaging, biotechnology and bioinformatics.
